Home > Health Encyclopedia
CAD - women; Coronary artery disease - women
People often do not consider heart disease a woman's disease. Yet cardiovascular disease is the leading killer of women over age 25. It kills nearly twice as many women in the United States as all types of cancer.
Men have a greater risk for heart disease earlier in life than women. Women's risk increases after menopause.
EARLY HEART DISEASE SIGNS
Women may have warning signs that go unnoticed for weeks or even years before a heart attack occurs.
ACT IN TIME
Recognizing and treating a heart attack right away improves your chance for survival. On average, a person having a heart attack will wait for 2 hours before calling for help.
Know the warning signs and always call 911 within 5 minutes of when symptoms begin. By acting quickly, you can limit damage to your heart.
MANAGE YOUR RISK FACTORS
A risk factor is something that increases your chance of getting a disease or having a certain health condition. You can change some risk factors for heart disease. Other risk factors you cannot change.
Women should work with their health care provider to address risk factors they can change.
Estrogen is no longer used to prevent heart disease in women of any age. Estrogen may increase the risk of heart disease for older women. However, it may still be used for some women to treat hot flashes or other medical problems.
Some women (especially those with heart disease) can take a low dose aspirin daily to help prevent heart attacks. Some women will be advised to low dose aspirin to prevent stroke. Aspirin can increase the risk for bleeding, so check with your provider before beginning daily aspirin treatment.
LIVE A HEALTHY LIFESTYLE
Some of the risk factors for heart disease that you CAN change are:
If you drink alcohol, limit yourself to no more than one drink per day. DO NOT drink just for the purpose of protecting your heart.
Good nutrition is important to your heart health, and it will help control some of your heart disease risk factors.
Gulati M and Bairey Merz CN. Cardiovascular disease in women. In: Mann DL, Zipes DP, Libby P, et al. eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 10th ed. Philadelphia, PA: Elsevier Saunders; 2014:chap 77.
Hansson GK, Hamsten A. Atherosclerosis, thrombosis, and vascular biology. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 25th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 70.
Meschia JF, Bushnell C, Boden-Albala B, Braun LT, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014 Dec;45(12):3754-832. Epub 2014 Oct 28. PMID: 25355838 www.ncbi.nlm.nih.gov/pubmed/25355838.
Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: A guideline from the American Heart Association. Circulation. 2011;123(11):1243-62. PMID: 21325087 www.ncbi.nlm.nih.gov/pubmed/21325087.
North American Menopause Society. The 2012 hormone therapy position statement of: The North American Menopause Society. Menopause. 2012 Mar;19(3):257-71. PMID: 22367731 www.ncbi.nlm.nih.gov/pubmed/22367731.
Ridker PM, Libby P, Buring JE. Risk markers and the primary prevention of coronary heart disease. In: Mann DL, Zipes DP, Libby P, et al. eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 10th ed. Philadelphia, PA: Elsevier Saunders; 2014:chap 42.
Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association. J Am Coll Cardiol. 2011 Nov 29;58(23):2432-46. Epub 2011 Nov 3. PMID: 22055990 www.ncbi.nlm.nih.gov/pubmed/22055990.